The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

NCPA, HDA, PhRMA, BIO, PCMA Testify Before House E&C

The House Energy and Commerce Subcommittee on Health held a hearing entitled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.”

Witnesses included: Lori M. Reilly, Esq., Chief Operating Officer, PhRMA; John F. Crowley, President and CEO, Biotechnology Innovation Organization (BIO); John Murphy, President and CEO, Association for Accessible Medicines (AAM); David Marin, President and CEO, Pharmaceutical Care Management Association (PCMA); Angie Boliver, President and CEO, Healthcare Supply Chain Association; Chester “Chip” Davis, Jr., President and CEO, Healthcare Distribution Alliance (HDA);  James Gelfand, President and CEO, The ERISA Industry Committee; B. Douglas Hoey, Chief Executive Officer, National Community Pharmacists Association (NCPA); and Rachel E. Sachs, Professor of Law, Washington University in St. Louis.

[Health Subcommittee: Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain. House Energy and Commerce Subcommittee on Health 11 Feb 2026.]